European Union - English - EMA (European Medicines Agency)

intervet international bv - leptospira interrogans serogroup canicola serovar portland-vere (strain ca-12-000), l. interrogans serogroup icterohaemorrhagiae serovar copenhageni (strain ic-02-001), l. interrogans serogroup australis serovar bratislava (strain as-05-073), l. kirschneri serogroup grippotyphosa serovar dadas (strain gr-01-005) - immunologicals - dogs - for active immunisation of dogs against:leptospira interrogans serogroup canicola serovar canicola to reduce infection and urinary excretion;l. interrogans serogroup icterohaemorrhagiae serovar copenhageni to reduce infection and urinary excretion;l. interrogans serogroup australis serovar bratislava to reduce infection;l. kirschneri serogroup grippotyphosa serovar bananal / lianguang to reduce infection and urinary excretion.

European Union - English - EMA (European Medicines Agency)

intervet international b.v. - porcine circovirus type 2 orf2 subunit antigen - immunologicals for suidae, inactivated viral vaccines - pigs - for the active immunisation of pigs to reduce viraemia, virus load in lungs and lymphoid tissues and virus shedding caused by pcv2 infection. to reduce loss of daily weight gain and mortality associated with pcv2 infection.

European Union - English - EMA (European Medicines Agency)

intervet international b.v. - porcine circovirus type 2 (pcv2) orf2 subunit antigen, mycoplasma hyopneumoniae j strain inactivated - immunologicals for suidae, inactivated viral and inactivated bacterial vaccines - pigs (for fattening) - for the active immunisation of pigs to reduce viraemia, virus load in lungs and lymphoid tissues, virus shedding caused by porcine circovirus type 2 (pcv2) infection, and severity of lung lesions caused by mycoplasma hyopneumoniae infection. to reduce the loss of daily weight gain during the finishing period in face of infections with mycoplasma hyopneumoniae and/or pcv2 (as observed in field studies)

European Union - English - EMA (European Medicines Agency)

intervet international bv - orbifloxacin, mometasone furoate, posaconazole - otologicals - dogs - treatment of acute otitis externa and acute exacerbations of recurrent otitis externa, associated with bacteria susceptible to orbifloxacin and fungi susceptible to posaconazole, in particular malassezia pachydermatis.

European Union - English - EMA (European Medicines Agency)

intervet international b. v. - tepoxalin - musculo-skeletal system - dogs - reduction of inflammation and relief of pain caused by acute and chronic musculoskeletal disorders.

European Union - English - EMA (European Medicines Agency)

intervet international b.v. - bluetongue virus vaccine, serotype 8 (inactivated) - immunologicals for ovidae - cattle; sheep - sheepfor the active immunisation of sheep from 2.5 months of age to prevent viraemia* and to reduce clinical signs caused by bluetongue virus serotype 8.cattlefor the active immunisation of cattle from 2.5 months of age to prevent viraemia* caused by bluetongue virus serotype 8.*(cycling value (ct) ≥ 36 by a validated rt-pcr method, indicating no presence of viral genome)

European Union - English - EMA (European Medicines Agency)

intervet international b.v. - cell-associated live recombinant turkey herpesvirus (strain hvp360), expressing the fusion protein of nd virus and the vp2 protein of ibd virus - avian herpes virus (marek's disease) + avian infectious bursal disease virus (gumboro disease) + newcastle disease virus/paramyxovirus - chicken; embryonated chicken eggs - for active immunisation of one-day-old chicks or 18-19-day-old embryonated chicken eggs:to reduce mortality and clinical signs caused by newcastle disease (nd) virus,to prevent mortality and to reduce clinical signs and lesions caused by infectious bursal disease (ibd) virus,to reduce mortality, clinical signs and lesions caused by marek’s disease (md) virus.

European Union - English - EMA (European Medicines Agency)

intervet international b.v. - live myxoma vectored rhd virus strain 009, live myxoma vectored rhd virus strain mk1899 - immunologicals for leporidae - rabbits - for active immunisation of rabbits from 5 weeks of age onwards to reduce mortality and clinical signs of myxomatosis and rabbit haemorrhagic disease (rhd) caused by classical rhd virus (rhdv1) and rhd type 2 virus (rhdv2).

European Union - English - EMA (European Medicines Agency)

intervet international b.v. - cell-associated live recombinant turkey herpesvirus (strain hvt/ndv/ilt) expressing the fusion protein of newcastle disease virus and the glycoproteins gd and gi of infectious laryngotracheitis virus - immunologicals for aves - embryonated chicken eggs; chicken - for active immunisation of one-day-old chicks or embryonated chicken eggs:to reduce mortality and clinical signs caused by newcastle disease (nd) virus,to reduce mortality, clinical signs and lesions caused by avian infectious laryngotracheitis (ilt) virus and marek’s disease (md) virus.

European Union - English - EMA (European Medicines Agency)

intervet international b.v. - live attenuated canine distemper virus strain onderstepoort: 105.1 – 106.5 tcid50, live recombinant canine parvovirus strain 630a: 105.1 – 106.7 tcid50 - immunologicals for canidae - dogs (small) - for the active immunisation of puppies from 4 weeks of age onwards to prevent clinical signs and mortality of canine distemper virus infection and canine parvovirus infection and to prevent viral excretion following canine distemper virus infection and following canine parvovirus infection.